China Digest: Nutshell raises $40m Series A+ round; UniXell closes $31.5m

A researcher at Shanghai UniXell Biotechnology is observing the growth condition of pluripotent stem cells under a microscope. Source: Shanghai UniXell Biotechnology

Eudora Wang

14 March, 2022

biotech Nutshell Therapeutics Shanghai UniXell Biotechnology

Printed by Unregistered user on Tue, 22 Jul 2025 14:38:32 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

China Digest: Nutshell raises $40m Series A+ round; UniXell closes $31.5m

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

China Digest: Legend Capital backs XDR SEC; Keyfunc nets nearly $15m

China Deal Review: Slowdown continues in Feb, but interest in chip investments sustains

Read more from Greater China

Startup funding in Greater China grows 13% in Q2 on Ximalaya’s $2.4b deal

Cannot rely solely on valuation metrics for AI investments: Cathay Innovation

China Digest: Nutshell raises $40m Series A+ round; UniXell closes $31.5m

Register now to enjoy 3 free articles per month, or log in to continue reading.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

China Digest: Legend Capital backs XDR SEC; Keyfunc nets nearly $15m

China Deal Review: Slowdown continues in Feb, but interest in chip investments sustains

Read more from Greater China

Startup funding in Greater China grows 13% in Q2 on Ximalaya’s $2.4b deal

Cannot rely solely on valuation metrics for AI investments: Cathay Innovation

Register now to enjoy 3 free articles per month,
or log in to continue reading.